Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
Olina Efthymiadou(London School of Economics and Political Science), Panos Kanavos(London School of Economics and Political Science)
Cited by 21
Related Papers
Socio-economic burden of rare diseases: A systematic review of cost of illness evidence
|Health Policy|2014|303